The identity of HAP1 was further confirmed by 2-DE Western blotting on the serum from healthy volunteers and grade 1 and 3 ovarian cancer patients using monoclonal anti-human haptoglobin antibody that binds to an epitope within HAP1. This evidence concerns the gene HAP1 and ovarian carcinoma.